Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
267 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00676650 | Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy(SUN 1120) | terminated | Phase 3 | 873 | PfizerINDUSTRY | 22 | Mar 8, 2013 | clinicaltrials |
| NCT00694382 | Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy(SAVE-ONCO) | completed | Phase 3 | 3,212 | SanofiINDUSTRY | 49 | Jan 23, 2013 |
| clinicaltrials |
| NCT00617669 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer(ENTHUSE M1C) | completed | Phase 3 | 1,494 | AstraZenecaINDUSTRY | 26 | Sep 10, 2012 | clinicaltrials |
| NCT00626548 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer(ENTHUSE M0) | terminated | Phase 3 | 2,577 | AstraZenecaINDUSTRY | 39 | Sep 3, 2012 | clinicaltrials |
| NCT00069745 | Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen | completed | Phase 3 | — | AgennixINDUSTRY | 15 | Aug 7, 2012 | clinicaltrials |
| NCT00369850 | Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98 | completed | Phase 3 | 458 | ETOP IBCSG Partners FoundationNETWORK | 8 | Jul 27, 2012 | clinicaltrials |
| NCT00004920 | Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura | completed | Phase 3 | 256 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Jul 18, 2012 | clinicaltrials |
| NCT00373113 | A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine | terminated | Phase 3 | 482 | PfizerINDUSTRY | 23 | Jun 25, 2012 | clinicaltrials |
| NCT00171340 | Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer. | completed | Phase 3 | 1,065 | Novartis PharmaceuticalsINDUSTRY | 28 | Apr 16, 2012 | clinicaltrials |
| NCT00336791 | Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer | completed | Phase 3 | 273 | M.D. Anderson Cancer CenterOTHER | 4 | Feb 14, 2012 | clinicaltrials |
| NCT01452672 | Resource-sparing Post-mastectomy Radiotherapy in Breast Cancer | unknown | Phase 3 | 600 | International Atomic Energy AgencyOTHER_GOV | 8 | Oct 17, 2011 | clinicaltrials |
| NCT00122772 | CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy | completed | Phase 3 | 601 | International Atomic Energy AgencyOTHER_GOV | 11 | Oct 14, 2011 | clinicaltrials |
| NCT00035425 | Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection | completed | Phase 3 | 120 | PfizerINDUSTRY | 10 | Dec 1, 2009 | clinicaltrials |
| NCT00191100 | Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix | completed | Phase 3 | 515 | Eli Lilly and CompanyINDUSTRY | 7 | Aug 11, 2009 | clinicaltrials |
| NCT00005966 | Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer | completed | Phase 3 | — | Eastern Cooperative Oncology GroupNETWORK | 4 | Feb 5, 2009 | clinicaltrials |
| NCT00449982 | Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts | completed | Phase 3 | 480 | MediGeneINDUSTRY | 7 | Mar 21, 2007 | clinicaltrials |
| NCT00035035 | A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas. | completed | Phase 3 | — | Eli Lilly and CompanyINDUSTRY | 18 | Jul 19, 2006 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials